Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-sequence facilitates analysis of mesenchymal stem cells treating with concanavalin A mice

ABSTRACT: RNA-sequence facilitates analysis of mesenchymal stem cells treating with concanavalin A mice

PROVIDER: PRJNA740028 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14882655_1.fastq.gz	Fastqsanger.gz
	SRR14882655_2.fastq.gz	Fastqsanger.gz
	SRR14882656_1.fastq.gz	Fastqsanger.gz
	SRR14882656_2.fastq.gz	Fastqsanger.gz
	SRR14882657_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNA-sequence facilitates analysis of mesenchymal stem cells treating with concanavalin A mice

Project description:Purpose: The goals of this study are to find the mechanisms of mesenchymal stem cells (MSC) ameliorating concanavalin A (Con A) induced inflammatory mice Methods: Liver tissues were harvested at 6h, 12h after Con A injected with/without MSC (n = 3 per group) for transcriptome profiling. Results: Filter the raw data obtained fromDNBSEQ-G400, and compare the filtered clean reads to the reference sequence. Quantitative analysis of known genes and new genes, differential expression analysis based on gene expression in different sample groups, GO function analysis, Pathway function analysis, cluster analysis, and protein interaction for the selected differentially expressed genes Network, transcription factor coding ability prediction and other in-depth mining analysis. Conclusions: Our study discoveres following processes were significantly affected: apoptosis, MAPK signaling pathway and cytokine-cytokine receptor interaction.

2023-07-01 | GSE178696 | GEO

Human Wharton's jelly-derived mesenchymal stem cells alleviate Concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis

Project description:RNA sequencing of mouse liver tissues 24 hours after Concanavalin A (Con A) administration.

2021-08-31 | GSE182182 | GEO

Human umbilical cord mesenchymal stem cells-derived exosomes for treating traumatic pancreatitis in rats

Project description:Human umbilical cord mesenchymal stem cells-derived exosomes for treating traumatic pancreatitis in rats

| PRJNA885082 | ENA

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Project description:RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children with metastatic rhabdomyosarcoma or other malignant mesenchymal tumors.

| 2006791 | ecrin-mdr-crc

Effect of YTHDF1 on concanavalin A-induced hepatitis

Project description:To investigate the effect of YTHDF1 on concanavalin A (ConA)-induced hepatitis , we performed RNA-seq with the total RNA extracted from the moue liver. Ythdf1-/- or wild type mice were intravenously injected with ConA (8 mg/kg) or saline for 8 hours. Then, the livers were collected, homogenized, and subjected to total RNA extraction.

2023-08-08 | GSE238229 | GEO

Human Wharton's jelly-derived mesenchymal stem cells alleviate Concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis

Project description:Human Wharton's jelly-derived mesenchymal stem cells alleviate Concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis

| PRJNA755269 | ENA

Mesenchymal stem cells for treating autoimmune dacryoadenitis.

Project description:Autoimmune dacryoadenitis, such as Sjögren syndrome, comprises multifactorial and complex diseases. Inflammation of the lacrimal gland plays a key role in the pathogenesis of diseases. Unfortunately, current treatment strategies, including artificial tears, anti-inflammatory drugs, punctual occlusion, and immunosuppressive drugs, are only palliative, and long-term administration of these strategies is associated with adverse effects that limit their utility. Hence, an effective and safe treatment for autoimmune dacryoadenitis is urgently needed. Mesenchymal stem cells (MSCs) have emerged as a promising tool for treating autoimmune dacryoadenitis, owing to their immunosuppressive properties, tissue repair functions, and powerful differentiation capabilities. A large number of studies have focused on the effect of MSCs on autoimmune diseases, such as autoimmune uveitis, inflammatory bowel disease, and collagen-induced arthritis, but few studies have, to date, unequivocally established the efficacy of MSCs for treating autoimmune dacryoadenitis. In this review, we discuss recent advances in MSC treatment for autoimmune dacryoadenitis.

| S-EPMC5460436 | biostudies-other

Effect of a DP1 agonist BW245C on concanavalin A-induced hepatitis

Project description:To elucidate the effect of a prostaglandin D2 receptor DP1 agonist BW245C on concanavalin A (ConA) hepatitis, we performed DNA microarray using SurePrint G3 Mouse GE 8x60K Microarray. Mice were treated with ConA for 3 or 24 hr with vehicle or BW245C . Livers were collected, homogenized, and subjected to total RNA extraction.

2015-06-01 | GSE45413 | GEO

CASB: A concanavalin A-based sample barcoding strategy for single-cell sequencing [snATAC]

Project description:We reported a Concanavalin A-based Barcoding Strategy (CASB) for single-cell and single-nucleus sample multiplexing, which could be followed by different single-cell sequencing techniques. The method involves minimal sample processing, thereby preserving intact transcriptomic or epigenomic patterns. Besides sample multiplexing, the CASB could further improve data quality through doublet identification.

2021-03-09 | GSE153115 | GEO

CASB: A concanavalin A-based sample barcoding strategy for single-cell sequencing [HAP1]

2021-03-09 | GSE153108 | GEO